Business Standard ... improperly manufactured, stored and tested. The generic drugs at issue were manufactured at Ranbaxy's facilities in Paonta Sahib and Dewas, India...
Genetic Engineering News Grifols will take a $26-million, roughly one-third stake in Aradigm under an exclusive, worldwide up-to-$116 million-plus license to develop and...
Business Standard They include acne drug Sotret, epilepsy and nerve pain drug gabapentin, and antibiotic ciprofloxacin . Ranbaxy, which first came under US FDA scanner in 2006 for violating manufacturing norms, has since struggled in its largest pharmaceutical market ... and more »
EON: Enhanced Online News (press release) OB) (“Aradigm”) today announced the signing of an exclusive, worldwide license for Aradigm's proprietary formulations of inhaled ciprofloxacin (Pulmaquin and Lipoquin™) for the treatment of severe respiratory diseases, including non-cystic fibrosis ...
Philippine Star Since sulfomide was introduced for the treatment of gonorrhea in the 1930s, N. gonorrhoeae has developed different mechanisms for evading each new first-line antimicrobial agent. Penicillins, tetracyclines, quinolones, and azithromycin have all fallen ...
